Loss of Function
Perry syndrome
Genotype
dctn1a
Mechanism
Loss of Function
Phenotype
Locomotor activity, Motor coordination, Muscle rigidity, Depression, Feeding behavior, Sleep, Cognitive dysfunction
Biomarker
NfL, NSE, Total tau, Dopamine, GFAP
Gene Expression Markers
DCTN1, TH, PGC1A, DRD2, BECN1, BAX, TNF-α, NRF2, HSP70
Physiology Changes
Bradykinesia, Irregular breathing pattern, Altered heart rate variability, Reduced dopamine release, Activated microglial and astrocytic responses
Histology Grading Endpoint
Cytoplasmic mislocalization, Swollen axons with accumulated cargo vesicles, Increased astrocytosis, Abnormal mitochondrial morphology, Dopaminergic neuron loss



